If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Rule 8.4 Disclosure

10 Mar 2009 11:20

RNS Number : 6127O
W.H. Ireland Group PLC
10 March 2009
 



10 March 2009

WH Ireland Group PLC ("WH Ireland")

Rule 8.4 Disclosure

As referred to in the announcement released by WH Ireland and Blue Oar PLC ("Blue Oar") on 2 March 2009, the irrevocable commitment received by WH Ireland from Evolve Capital PLC ("Evolve") (the "Evolve Undertaking") to vote in favour of (or accept) the possible offer by WH Ireland for Blue Oar (the "Possible Offer") in respect of Evolve's entire holding of Blue Oar shares (representing approximately 64.9 per cent. of the existing issued share capital of Blue Oar) ceased to be binding if, inter alia, an announcement of a firm intention to make an offer under Rule 2.5 of the City Code was not made by 12 noon on 9 March 2009.

WH Ireland and Blue Oar further announced on 9 March 2009 that discussions were well advanced and ongoing between the parties and that a further announcement would be made in due course.

As the Evolve Undertaking has now ceased to be binding, WH Ireland announces it no longer has a disclosable interest in the securities of Blue Oar under the provisions of Rule 8.4 of the City Code.

Enquiries:

WH Ireland

Richard Ford

Tel: 020 7220 0475

Oriel Securities Ltd

Tom Durie

Jonathan Walker

Tel: 020 7710 7600

Biddicks (Financial PR to WH Ireland)

Zoe Biddick

Tel: 020 7448 1000

Dealing Disclosure Requirements

The disclosure requirements are set out in more detail in Rule 8 of the Code. In particular, under the provisions of Rule 8.3 of the Code, if any person is, or becomes, 'interested' (directly or indirectly) in one per cent. or more of any class of 'relevant securities' of Blue Oar or WH Ireland, all 'dealings' in any 'relevant securities' of that company (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the offer period otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Blue Oar or WH Ireland, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Blue Oar or WH Ireland by WH Ireland or Blue Oar, or by any of their respective 'associates' (within the meaning of the Code), must also be disclosed by no later than 12.00 p.m. (London time) on the Business Day following the date of the relevant transaction.

A disclosure table giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8 of the Code, you should consult the Panel.

If you are in any doubt as to the application of Rule 8 to you, please contact an independent financial adviser authorised under the Financial Services and Markets Act 2000, consult the Panel's website at www.thetakeoverpanel.org.uk or contact the Panel on telephone number +44 (020) 7638 0129; fax: +44 (020) 7236 7013.

This Announcement does not constitute, or form part of, an offer or invitation to purchase any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPMGGMFMGVGLZM
Date   Source Headline
15th Aug 20232:59 pmRNSResult of General Meeting and Total Voting Rights
31st Jul 20237:25 amRNSPosting of Circular and Notice of General Meeting
28th Jul 20238:53 amRNSResult of Placing
28th Jul 20237:00 amRNSTrading Update & Proposed Placing
22nd Jun 20239:05 amRNSESOT Purchases
15th Jun 20234:57 pmRNSESOT Purchases
24th Apr 20232:11 pmRNSESOT Purchases
21st Apr 20239:20 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSIssue of Equity
3rd Apr 20237:00 amRNSYear End Trading Update
14th Mar 202311:39 amRNSESOT Purchases
9th Feb 20239:10 amRNSESOT Trading
25th Jan 20238:47 amRNSTotal Voting Rights
17th Jan 20238:44 amRNSESOT Purchases
11th Jan 202310:45 amRNSIssue of Equity - Total Voting Rights
20th Dec 20222:08 pmRNSTR-1: Notification of major holdings
16th Dec 202210:19 amRNSRecent appointments across the Group
16th Dec 20227:00 amRNSInterim Results
7th Dec 20227:00 amRNSESOT Purchases
7th Nov 20225:00 pmRNSESOT Trading
4th Nov 20223:45 pmRNSESOT Trading
4th Oct 20228:18 amRNSESOT Purchases
8th Sep 20224:10 pmRNSResult of AGM
8th Sep 20228:23 amRNSESOT Purchases
5th Aug 20227:00 amRNSESOT Purchases
1st Aug 202210:18 amRNSPDMR Shareholding
27th Jul 20227:00 amRNSFinal Results and Notice of AGM
19th Jul 20227:00 amRNSConfirmation of Chairman Appointment
12th Jul 20227:00 amRNSESOT Purchases
20th Jun 20227:00 amRNSESOT Purchases
10th May 20227:00 amRNSNew Debt Capital Markets Business
6th May 20227:37 amRNSESOT Purchases
27th Apr 20224:05 pmRNSIssue of Options
12th Apr 20228:51 amRNSESOT Purchases
31st Mar 20227:00 amRNSBoard Changes
9th Mar 20227:00 amRNSESOT Purchases
17th Feb 202211:23 amRNSPDMR Shareholdings
15th Feb 20227:00 amRNSDirectorate Update
11th Feb 20224:47 pmRNSTR-1: Notification of Major Holdings
11th Feb 20227:00 amRNSTR-1: Notification of Major Holdings
10th Feb 20229:11 amRNSESOT Purchases
7th Feb 202212:39 pmRNSIssue of Equity - Total Voting Rights
24th Jan 20225:12 pmRNSPDMR Shareholdings
18th Jan 20227:00 amRNSPDMR Shareholding
13th Jan 20227:00 amRNSDirectorate Change
6th Jan 20227:00 amRNSESOT Purchases
20th Dec 20217:00 amRNSAppointment of Head of Private Growth Capital
17th Dec 202111:32 amRNSPrivate Capital Team Update
15th Dec 20217:00 amRNSESOT Purchases
7th Dec 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.